Fractionated stereotactic radiation therapy for intact brain metastases

Fractionated stereotactic radiation therapy for intact brain metastases

Purpose: Limited data exist on fractionated stereotactic radiation therapy (FSRT) for brain metastases. We sought to evaluate the safety and efficacy of FSRT and further define its role in brain metastasis management. Methods and materials: A total of 72 patients were treated with linear accelerator...

Full description

Bibliographic Details
Main Authors:	Samuel R. Marcrom, MD, Andrew M. McDonald, MD, Jonathan W. Thompson, MD, Richard A. Popple, PhD, Kristen O. Riley, MD, James M. Markert, MD, Christopher D. Willey, MD, PhD, Markus Bredel, MD, PhD, John B. Fiveash, MD
Format:	Article
Language:	English
Published:	Elsevier 2017-10-01
Series:	Advances in Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452109417301112

Similar Items

Focal Management of Large Brain Metastases and Risk of Leptomeningeal Disease
by: Samuel R. Marcrom, MD, et al.
Published: (2020-01-01)

Control and Toxicity in Melanoma Versus Other Brain Metastases in Response to Combined Radiosurgery and PD-(L)1 Immune Checkpoint Inhibition
by: Roman L. Travis, BS, et al.
Published: (2021-01-01)

Single fraction stereotactic radiosurgery for multiple brain metastases
by: Dror Limon, MD, et al.
Published: (2017-10-01)

Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic Radiosurgery
by: David J. Carpenter, MD, et al.
Published: (2023-03-01)

Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost in Patients With Spinal Metastases
by: Antonio Pontoriero MD, et al.
Published: (2020-04-01)

The virtual cone: A novel technique to generate spherical dose distributions using a multileaf collimator and standardized control-point sequence for small target radiation surgery
by: Richard A. Popple, PhD, et al.
Published: (2018-07-01)

Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery
by: Ingrid Digernes, MSc, et al.
Published: (2018-10-01)

Radiation Therapy Practice Patterns for Brain Metastases in the United States in the Stereotactic Radiosurgery Era
by: Andrew B. Barbour, PhD, et al.
Published: (2020-01-01)

Early Detection of Leptomeningeal Metastases Among Patients Undergoing Spinal Stereotactic Radiosurgery
by: Morgan E. Freret, MD, PhD, et al.
Published: (2023-03-01)

The Effect of Slice Thickness on Contours of Brain Metastases for Stereotactic Radiosurgery
by: Sara L. Thrower, PhD, et al.
Published: (2021-07-01)

Single-fraction Stereotactic Body Radiation Therapy versus Conventionally Fractionated Radiation Therapy for the Treatment of Prostate Cancer Bone Metastases
by: Robert W. Gao, BS, et al.
Published: (2019-04-01)

The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicity
by: Rachel B. Jimenez, MD, et al.
Published: (2017-07-01)

Practical Considerations for the Implementation of a Stereotactic Body Radiation Therapy Program for Oligo-Metastases
by: Matthew Chan, MD, FRCPC, et al.
Published: (2021-01-01)

Safety and Feasibility of Stereotactic Radiosurgery for Patients with 15 or more Brain Metastases
by: Rituraj Upadhyay, MD, et al.
Published: (2024-07-01)

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
by: Pierre-Marie Pialat, MD, et al.
Published: (2021-07-01)

Stereotactic Body Radiation Therapy and Concurrent Targeted Therapy for Lung Metastases in Pediatric Sarcoma
by: Riley M. Goldsmith, BS, et al.
Published: (2024-07-01)

Spatially fractionated stereotactic body radiation therapy (Lattice) for large tumors
by: Sai Duriseti, MD, PhD, et al.
Published: (2021-05-01)

ExacTrac X-Ray 6D Imaging During Stereotactic Body Radiation Therapy of Spinal and Nonspinal Metastases
by: Ahmed Hadj Henni PhD, et al.
Published: (2023-10-01)

Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity
by: Diego A.S. Toesca, MD, et al.
Published: (2018-10-01)

Effect of Target Changes on Target Coverage and Dose to the Normal Brain in Fractionated Stereotactic Radiation Therapy for Metastatic Brain Tumors
by: Hideharu Miura, PhD, et al.
Published: (2023-11-01)

Stereotactic Radiosurgery Results for Patients With Brain Metastases From Gastrointestinal Cancer: A Retrospective Cohort Study of 802 Patients With GI-GPA Validity Test
by: Masaaki Yamamoto, MD, PhD, et al.
Published: (2021-11-01)

Stereotactic Radiosurgery for Brain Metastases in Patients With Small Cell Lung Cancer
by: Victoria H. Wang, BS, et al.
Published: (2023-09-01)

Single and Multifraction Spine Stereotactic Body Radiation Therapy and the Risk of Radiation Induced Myelopathy
by: J. John Lucido, PhD, et al.
Published: (2022-11-01)

Single-Isocenter Multitarget Stereotactic Radiosurgery Is Safe and Effective in the Treatment of Multiple Brain Metastases
by: Joshua D. Palmer, MD, et al.
Published: (2020-01-01)

Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma
by: Jonathan E. Schoenhals, BS, et al.
Published: (2021-09-01)

Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors
by: Jonathan W. Lischalk, MD, et al.
Published: (2018-07-01)

Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Multiple Pulmonary Oligometastases or Synchronous Primary Lung Cancer
by: Noriko Kishi, MD, et al.
Published: (2022-05-01)

Radiation-Induced Peripheral Neuropathy After Thoracic Stereotactic Ablative Radiotherapy: Case Report
by: Ha H. Pham, MD, PhD, et al.
Published: (2022-08-01)

Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac
by: Stefania Naccarato, PhD, et al.
Published: (2022-05-01)

Pretreatment Spatially Aware Magnetic Resonance Imaging Radiomics Can Predict Distant Brain Metastases (DBMs) After Stereotactic Radiosurgery/Radiation Therapy (SRS/SRT)
by: Joseph Bae, MS, et al.
Published: (2024-05-01)

Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma
by: Yi-Xing Chen MD, PhD, et al.
Published: (2020-07-01)

Recent Advances and Challenges in Stereotactic Body Radiotherapy
by: Atsuto Katano MD, PhD, et al.
Published: (2024-02-01)

Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study
by: Kamran A. Ahmed, MD, et al.
Published: (2021-11-01)

Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy
by: Dawn Owen, MD, PhD, et al.
Published: (2016-01-01)

Stereotactic Radiation Therapy for an Arteriovenous Malformation of the Oral Tongue: A Teaching Case
by: Emily C. Merfeld, MD, et al.
Published: (2022-05-01)

Preoperative Dural Contact and Recurrence Risk After Surgical Cavity Stereotactic Radiosurgery for Brain Metastases: New Evidence in Support of Consensus Guidelines
by: Matthew Susko, MD, et al.
Published: (2019-07-01)

Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation
by: Comron Hassanzadeh, MD, MPH, et al.
Published: (2021-01-01)

How Does the Number of Brain Metastases Correlate With Normal Brain Exposure in Single-Isocenter Multitarget Multifraction Stereotactic Radiosurgery
by: Dandan Zheng, PhD, et al.
Published: (2024-06-01)

Tumor Lysis Syndrome in a Patient With Metastatic Endometrial Cancer Treated With Lattice Stereotactic Body Radiation Therapy
by: Joshua P. Schiff, MD, et al.
Published: (2022-01-01)

An Analysis of Clinical Toxic Effects and Quality of Life as a Function of Radiation Dose and Volume After Lung Stereotactic Body Radiation Therapy
by: Suneetha Devpura, PhD, et al.
Published: (2021-11-01)